This cross-border acquisition will help NephroPlus to access the $400 million Philippines dialysis market and the company aims to clock a business of $50 million by 2025.
China claims sovereignty over virtually the entire South China Sea, which is also claimed in whole or in part by Taiwan, the Philippines, Brunei, Malaysia and Vietnam.